SACRAMENTO – A California woman alleges a medication used to treat heartburn and gastroesophageal reflux disease caused kidney damage.
Penelope Costamagna and Gary Costamagna filed a complaint on Feb. 23 in the U.S. District Court for the Eastern District of California against The Procter & Gamble Co., Astrazeneca Pharmaceuticals LP and Does 1 to 50 alleging strict products liability, negligent misrepresentation and loss of consortium.
According to the complaint, the plaintiffs allege that in 2016, Penelope Costamagna suffered physical injuries, including damages to her kidney, due to taking Prilosec. She alleges she required a kidney transplant because of proton pump inhibitor use. The plaintiffs holds The Procter & Gamble Co., Astrazeneca Pharmaceuticals LP and Does 1 to 50 responsible because the defendants allegedly had a duty to include appropriate warnings against the continued use of the drug and failed to appropriately warn Penelope Costamagna's health care providers about the side effects and risks.
The plaintiffs request a trial by jury and seek non-economic damages, economic damages, all legal fees, interest, judgment of no more than $5 million and any other relief as the court deems just. They are represented by Clayeo C. Arnold and Joshua H. Watson of Clayeo C. Arnold in Sacramento.
U.S. District Court for the Eastern District of California Case number 2:17-cv-00409-MCE-EFB